Three-year follow-up of accelerated transepithelial corneal cross-linking for progressive paediatric keratoconus.

Mi TianWeijun JianXiaoyu ZhangLing SunXing-Tao Zhou

Published in: The British journal of ophthalmology (2020)

ATE-CXL is a safe and effective treatment in paediatric progressive keratoconus patients, leading to stable keratometry and corneal thickness throughout the 36-month follow-up.

Keyphrases

end stage renal disease
multiple sclerosis
optical coherence tomography
intensive care unit
emergency department
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
wound healing
combination therapy